| Serial Number | 98660534 |
| Word Mark | T G TRAFFIKGENE |
| Filing Date | Monday, July 22, 2024 |
| Status | 649 - ACTION CONTINUING FINAL - MAILED |
| Status Date | Thursday, February 19, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Indication of Colors claimed | The color(s) green is/are claimed as a feature of the mark. |
| Description of Mark | The mark consists of a green stylized double helix design with a stylized green letter "T" on the left of the helix and stylized green "G" on the right of the helix. Below is the word "TRAFFIKGENE" in green stylized font. |
| Goods and Services | Pharmaceuticals in the nature of advanced therapeutic medicinal products, namely RNA therapies, gene and cell therapies, as well as enzyme replacement therapies, immunotherapies, and vaccines all for the treatment of oncological disorders, metabolic diseases, autoimmune diseases, infectious diseases, and other rare genetic diseases produced by mutations causing a missing gene or the expression of a faulty one; medical preparations in the nature of medical preparations for gene therapy, immunotherapy, enzyme replacement and vaccinations all for the treatment of oncological disorders, metabolic diseases, autoimmune diseases, infectious diseases, and other rare genetic diseases produced by mutations causing a missing gene or the expression of a faulty one; veterinary preparations for gene therapy for pets and farm animals, all for the treatment of oncological disorders, metabolic diseases, autoimmune diseases, infectious diseases, and other rare genetic diseases produced by mutations causing a missing gene or the expression of a faulty one; sanitary preparations for medical purposes; Nucleic acid sequences for medical and veterinary purposes; Biological reagents for medical use; Biological reagents for veterinary use; Biological adjuvants for medical purposes; Biological preparations for the treatment of cancer; Biological tissue cultures for medical purposes; Biological tissue cultures for veterinary purposes; Medicines for human purposes being advanced therapeutic medicinal products in the nature of RNA therapy preparations, namely, mRNA, siRNA, and antisense oligonucleotide therapies for the treatment of cancer, genetic disorders, infectious diseases, and immune-mediated diseases; gene therapy preparations for the treatment of inherited genetic disorders, cancer, and rare diseases; enzyme replacement therapies for the treatment of metabolic and lysosomal storage disorders; vaccines for prophylactic and therapeutic use; immunotherapies for the treatment of cancer, autoimmune diseases, and inflammatory diseases; and cell therapies for the treatment of cancer, genetic disorders, and degenerative diseases; Medicines for human purposes being RNA therapies, gene and cell therapies, as well as enzyme replacement therapies, immunotherapies, and vaccines all for the treatment of oncological disorders such as melanoma or lung cancer, metabolic diseases such as lysosomal storage diseases, autoimmune diseases, infectious diseases, and other rare genetic diseases produced by mutations causing a missing gene or the expression of a faulty one; Biological preparations for medical purposes for the treatment of rare diseases, genetic diseases, cancer or the prophylaxis of viral diseases; Pharmaceutical preparations, namely, advanced therapeutic medicinal products being pharmaceuticals for enzyme replacement therapies, immunotherapies, and vaccines for the treatment of oncological disorders such as melanoma or lung cancer, metabolic diseases such as lysosomal storage diseases, autoimmune diseases, infectious diseases, and other rare genetic diseases produced by mutations causing a missing gene or the expression of a faulty one; Nutraceutical preparations for therapeutic and medical purposes for the treatment of rare diseases, genetic diseases, cancer and the prophylaxis of viral diseases; Chemical preparations for pharmaceutical purposes, namely, for the treatment of rare diseases, genetic diseases, cancer and the prophylaxis of viral diseases; Chemical preparations for medical purposes, namely for the treatment of rare diseases, genetic diseases, cancer and the prophylaxis of viral diseases; Chemico-pharmaceutical preparations in the nature of formulations comprising at least a mixture of one or more peptide or peptide amphiphile molecules and one or more nucleic acids and proteins for the treatment of oncological disorders, metabolic diseases, autoimmune diseases, infectious diseases, and other rare genetic diseases produced by mutations causing a missing gene or the expression of a faulty one; Chemical reagents for medical or veterinary purposes; Chemical preparations for veterinary purposes, namely formulations comprising at least a mixture of one or more peptide or peptide amphiphile molecules and one or more nucleic acids and proteins for the treatment of oncological disorders, metabolic diseases, autoimmune diseases, infectious diseases, and other rare genetic diseases produced by mutations causing a missing gene or the expression of a faulty one; Nucleic acids for medical or veterinary purposes; Nucleic recombinant acids for medical or veterinary purposes |
| Pseudo Mark | T G TRAFFIC GENE |
| Goods and Services | Chemicals used in industry and science; Biological preparations for use in industry and science; Chemical reagents for molecular biology, other than for medical or veterinary use; Nucleic acids, other than for medical or veterinary purposes; Nucleic recombinant acids, other than for medical or veterinary purposes; Nucleic acids for scientific purposes; Nucleic acid for use in nucleic acid amplification processes, other than for medical use; Biological tissue cultures, other than for medical or veterinary purposes; Reagents for use in scientific apparatus for chemical or biological analysis; Biological preparation for use in cell cultures other than for medical or veterinary use; Biological indicators for monitoring sterilization processes other than for medical or veterinary purposes; Reagents for use in biological processing other than for medical or veterinary purposes; Biological preparations, other than for medical or veterinary purposes, namely, biological preparations for use in industry and science, namely, the agriculture and the food industry; Aldehydes; Active chemical ingredients for use in the manufacture of pharmaceuticals, transfection reagents for use in the manufacture of pharmaceuticals, in protein production, the manufacture of biologics, namely viral vectors and vaccine production, the engineering of producer and stable cell lines for drug discovery and preclinical development, and laboratory kits for use in transfection procedures for use in the manufacture of pharmaceuticals, in protein production, the manufacture of biologics, namely viral vectors and vaccine production, the engineering of producer and stable cell lines for drug discovery and preclinical development which are comprised of a peptide-based transfection reagent, nucleic acids, proteins, small molecules being organic compounds, or a combination of these elements for enhancing membrane permeation for the introduction of relevant biological molecules, gene material, proteins, peptides, and antibodies inside cultured cells; Salts being chemical preparations in the nature of salts for industrial, pharmaceutical and agricultural purposes |
| Goods and Services | Scientific and technological services, namely, scientific research, analysis, testing, modeling, chemical design, synthesis and characterization as well as related research and design services in the field of bioinformatics and structure-activity relationship research, such as that driven by machine learning and related algorithms; Research relating to molecular sciences; Analysis in the field of molecular biology; Research in the field of gene editing technology; Biological analysis; Biological development services; Biological laboratory services; Biological research and analysis; Services of a chemical and/or biological laboratory; Genetic mapping for scientific purposes; Scientific research in the field of genetics; Biological research; Scientific research; Culturing of cells for others for scientific research purposes; Medical research; Chemical research; Scientific laboratory services; Chemistry services in the nature of research and development services in the field of peptide chemistry, organic chemistry, supramolecular chemistry and biological chemistry |
| Pseudo Mark | TRAFFIC GENE TRAFFIC GENE |
| Goods and Services | Medical services; Genetic testing for medical purposes; Medical treatment using cultured cells |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 22, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 22, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 22, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 22, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Santiago de Compostela 15782 ES |
| Event Date | Event Description |
| Monday, July 22, 2024 | NEW APPLICATION ENTERED |
| Monday, February 10, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, February 10, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, February 11, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, February 11, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, February 11, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, February 11, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, April 28, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, April 28, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, April 29, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, July 8, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, July 29, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 29, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 29, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, July 29, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 29, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 29, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, September 24, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 24, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, September 24, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, October 14, 2025 | FINAL REFUSAL WRITTEN |
| Tuesday, October 14, 2025 | FINAL REFUSAL E-MAILED |
| Tuesday, October 14, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, December 18, 2025 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Thursday, December 18, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, December 18, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 6, 2026 | ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED |
| Tuesday, January 6, 2026 | ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED |
| Tuesday, January 6, 2026 | NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED |
| Tuesday, January 13, 2026 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Tuesday, January 13, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 13, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, February 19, 2026 | ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED |
| Thursday, February 19, 2026 | ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED |
| Thursday, February 19, 2026 | NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED |